Analysed QIAGEN N.V. (QGEN:NYSE) News Sources
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel
10-08-2026
yahoo.com
Will FDA Clearance of QIAstat-Dx Bloodstream Panel Change Qiagen's (QGEN) Syndromic Testing Narrative?
13-08-2026
yahoo.com
What is the current price of QIAGEN N.V. (QGEN:NYSE)?
The current price of QIAGEN N.V. (QGEN:NYSE) is $43.74.
QIAGEN N.V. (QGEN:NYSE) absolute price change since previous trading day?
The absolute price change of QIAGEN N.V. (QGEN:NYSE) since the previous trading day is $0.38.
QIAGEN N.V. (QGEN:NYSE) percentage price change since previous trading day?
The percentage price change of QIAGEN N.V. (QGEN:NYSE) since the previous trading day is 0.8764%.
What is the most recent average sentiment score for QIAGEN N.V. (QGEN:NYSE)?
The most recent average sentiment score for QIAGEN N.V. (QGEN:NYSE) is 61 out of 100.
What is the most recent average sentiment for QIAGEN N.V. (QGEN:NYSE)?
The most recent sentiment for QIAGEN N.V. (QGEN:NYSE) is .
SEC-8K** Filing Available For QIAGEN N.V. (QGEN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.